-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Globus Medical, Raises Price Target to $114

Benzinga·02/25/2026 10:30:17
Listen to the news
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $112 to $114.